Whitener Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$457K Buy
912
+235
+35% +$113K 0.1% 131
2026
Q1
$333K Buy
677
+115
+20% +$62.4K 0.08% 145
2025
Q4
$326K Sell
562
-70
-11% -$39.6K 0.07% 138
2025
Q3
$307K Buy
632
+64
+11% +$29.8K 0.07% 139
2025
Q2
$230K Buy
568
+18
+3% +$7.53K 0.06% 147
2025
Q1
$274K Buy
550
+20
+4% +$10.8K 0.08% 135
2024
Q4
$276K Hold
530
0.08% 132
2024
Q3
$328K Buy
530
+145
+38% +$85.8K 0.09% 126
2024
Q2
$213K Buy
385
+10
+3% +$5.73K 0.06% 145
2024
Q1
$218K Buy
+375
New +$210K 0.07% 141

Other funds holding TMO

Whitener Capital Management's TMO Position: Q2 2026 in Review

Whitener Capital Management increased its Thermo Fisher Scientific (TMO) stake by 35% in Q2 2026, buying an estimated $113K and bringing the position to 912 shares worth $457K. The position accounts for 0.1% of the portfolio, ranked #131.

Whitener Capital Management first reported a position in TMO in Q1 2024 and has held it in 10 quarters since. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Whitener Capital Management held 912 shares of Thermo Fisher Scientific worth $457K as of Q2 2026.
  • Whitener Capital Management bought 235 Thermo Fisher Scientific shares in Q2 2026, an estimated $113K.
  • Thermo Fisher Scientific made up 0.1% of Whitener Capital Management's portfolio in Q2 2026, its #131 holding.
  • Whitener Capital Management first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 10 quarters since.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Whitener Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.